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ISIPADU KELENJAR PARATIROID SEBAGAI SATU PETUNJUK UNTUK 
PARATIROIDECTOMI BAGI PESAKIT HIPERPARATIROIDISME 
SEKUNDER 
 
ABSTRAK 
 
Latar Belakang 
 
Hiperparatiroidisme sekunder berlaku akibat kegagalan buah pinggang untuk 
menyediakan homeostasis kalsium dan fosfat yang mencukupi dalam penyakit buah 
pinggang kronik. Dalam jangka masa panjang, terdapat gangguan berkaitan 
metabolisme tulang yang berikutan, yang membawa kepada ketidakupayaan fizikal. 
Rawatan hiperparatiroidisme sekunder berpusat di sekitar kawalan hiperphosphatemia 
dan hipocalcemia , dan ini boleh dicapai melalui terapi perubatan atau pembedahan 
untuk mengeluarkan kelenjar paratiroid. Kajian ini bertujuan untuk menentukan isipadu 
kelenjar paratiroid berkaitan dengan tahap hiperplasia, dan seterusnya menggunakan 
isipadu kelenjar paratiroid sebagai penunjuk untuk paratiroidectomi. 
 
Kaedah Kajian 
  
Ini adalah kajian kes yang dijalankan di Hospital Queen Elizabeth II, 
Kota Kinabalu , Sabah . Ia melibatkan pesakit peringkat akhir penyakit buah pinggang 
menjalani rawatan dialisis, yang telah menjalani paratiroidectomi untuk 
hiperparatiroidisme menengah dari 1 Januari 2012 hingga 31 Disember 2017. Kajian ini 
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merangkumi semua pesakit yang telah menjalani paratiroidectomi dalam tempoh kajian 
itu, dan tidak termasuk pesakit dengan hiperparatiroidisme utama, pesakit dengan 
penanda biokimia yang tidak lengkap sebelum pembedahan, dan mereka yang 
mempunyai dokumentasi hasil histopatologi yang tidak lengkap . Data tersebut 
kemudiannya dianalisis dan hasil yang dihasilkan menggunakan perisian Perisian 
Statistik Sosial Sains (SPSS) versi 24. 
  
  
Keputusan 
  
56 pesakit yang telah menjalani paratiroidectomi untuk hiperparatiroidisme sekunder 
telah dikaji. Kami mencatatkan keputusan yang kurang baik dengan ultrasonografi 
untuk mengesan kelenjar paratiroid dalam tetapan kami. Tidak terdapat hubungan yang 
signifikan antara isipadu sebenar kelenjar paratiroid seperti yang dilihat pada 
pemeriksaan histopatologi, atau isipadu berdasarkan ultrasonografi dengan tahap 
hiperplasia kelenjar. Tidak terdapat juga hubungan yang signifikan di antara tahap iPTH 
sebelum pembedahan dengan saiz kelenjar mahupun tahap hyperplasia kelenjar 
tersebut. 
 
 
 
 
 
 
 
 9 
 
 
Kesimpulannya 
  
Isipadu kelenjar paratiroid tidak boleh digunakan sebagai penunjuk 
tunggal paratiroidectomi. Walaupun ultrasonografi berguna sebagai penilaian yang 
tidak invasif terhadap tindak balas terhadap terapi perubatan, kami gagal untuk 
menunjukkan kepentingan isipadu kelenjar dengan tahap hiperplasia, yang 
menunjukkan tindak balasnya terhadap terapi perubatan. Oleh itu kami mencadangkan 
bahawa parameter lain seperti tahap iPTH sebelum pembedahan dan gejala gangguan 
tulang mineral perlu diambil kira sebelum paratiroidectomi. 
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THESIS TITLE 
 
ABSTRACT 
 
Background 
 
Secondary hyperparathyroidism occurs as a result of the failure of the kidneys to 
provide adequate calcium and phosphate homeostasis in chronic kidney disease. In the 
long run, there are other associated disorders of bone metabolism that follows, leading 
to incapacitating disabilities. Treatment of secondary hyperparathyroidism is centered 
around the control of hyperphosphatemia and hypocalcemia, and this can be achieved 
by medical therapy or surgery to remove the parathyroid glands. This study aims to 
determine the volume of the parathyroid gland in relation to its degree of hyperplasia, 
and subsequently to use the volume of the parathyroid gland as an indicator for 
parathyroidectomy. 
 
Methods 
 
This is a case control study conducted in Hospital Queen Elizabeth II, Kota Kinabalu, 
Sabah. It involves patients with end stage renal disease on dialysis, who have undergone 
parathyroidectomy for secondary hyperparathyroidism from 1st January 2012 until 31st 
December 2017. The study includes all patients who have undergone 
parathyroidectomy in the study period, and excludes patients with primary 
hyperparathyroidism, patients with incomplete biochemical markers prior to surgery, 
and those with incomplete documentation of histopathological results. The data is then 
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analyzed and results generated using Statistical Package for the Social Sciences (SPSS) 
software version 24 . 
 
 
Results 
 
56 patients who had undergone parathyroidectomy for secondary hyperparathyroidism  
were studied. We noted poor results with ultrasonography on detection of parathyroid 
glands in our setting. There was no significant relationship between the actual volume 
of the parathyroid gland as seen on histopathological examination, or the volume on 
ultrasound with the degree of hyperplasia of the gland. There was also no significant 
relationship between the preoperative iPTH levels an the size of the gland nor the 
degree of hyperplasia of the gland. 
 
Conclusion 
 
The volume of the parathyroid gland should not be used as the sole indicator of 
parathyroidectomy. While ultrasound is useful as a non-invasive assessment of the 
response to medical therapy, we failed to demonstrate the significance of the volume of 
the gland with the degree of hyperplasia, which reflects on its response to medical 
therapy. Therefore we suggest that other parameters such as preoperative iPTH levels 
and symptoms of mineral bone disorders should be taken into consideration prior to 
parathyroidectomy. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Brief History 
 
The parathyroid gland is one of the last anatomical discoveries in humans. Sir Richard 
Owen was the first to describe the parathyroid glands in a rhinoceros. However, it was 
Ivar Sandstrom who discovered the parathyroid gland in the late 19th century in 
Uppsala, Sweden. He noted upon dissection of autopsy cases that there was a small 
organ on both sides of the inferior border of the thyroid gland, which was 
distinguishably different from the thyroid gland and lymph node. The functional 
importance of the parathyroid glands were discovered by Eugene Gley, who described 
the fatal seizures that followed after thyroidectomy, and through a series of 
experiments, he was able to conclude that it was the removal of the parathyroid glands 
that contributed to this effect. Giulio Vassale and Francessco Generali further 
demonstrated tetany after thyroid and parathyroid removal, and later on in the early 20th 
century, others were able to demonstrate fatal tetany after complete parathyroid 
removal, which proved that parathyroid tissue was absolutely necessary for survival 
(Medvei, 1982; Eknoyan, 1995). 
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1.2 Surgical Anatomy 
 
The parathyroid glands are usually 4 in number, and have different embryological 
origins. The superior parathyroid glands originate from the fourth branchial pouch, 
whereas the inferior parathyroid glands originate from the third branchial pouch. During 
migration of the glands, the superior parathyroids settle at the posterior aspect of the 
thyroid gland near the cricothyroid junction, while the inferior parathyroids have a more 
variable descent. Common sites to locate the inferior parathyroid glands are inferior, 
lateral or posterior to the inferior thyroid pole below the inferior thyroid artery, in the 
thymus, or even in the anterior mediastinum (Miller, 2003). The blood supply to the 
parathyroid glands are derived from the inferior thyroid arteries, and to a lesser extent 
the superior thyroid arteries. 
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Figure 1: Anatomy of superior and inferior parathyroid glands
 
Figure 2: Anatomy of inferior parathyroid gland in relation to recurrent laryngeal 
nerve (Ghorayeb, 2014) 
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1.3 Pathophysiology 
 
1.3.1 Pathophysiology of Secondary Hyperparathyroidism 
 
Fuller Albright described parathyroid hyperplasia, and explained that there was a 
distinction between parathyroid hyperplasia with hyperparathyroidism and 
compensatory hyperplasia of parathyroid glands (Albright et al., 1934). This formed the 
basis of the difference between primary, secondary, and tertiary hyperparathyroidism. 
 
Secondary hyperparathyroidism (sHPT) occurs most commonly “secondary” to chronic 
kidney disease (CKD), and therefore frequently referred to as renal 
hyperparathyroidism. The pathophysiology lies in the relationship between CKD  and 
parathyroid hyperplasia. The inability of the kidneys to maintain proper calcium and 
phosphorus homeostasis stimulates glandular hyperplasia. This happens when there is 
initial failure of the kidneys to excrete phosphate, leading to hyperphosphatemia.  
 
It is believed that hyperphosphatemia is the major factor that causes parathyroid gland 
hyperplasia in sHPT. There were experimental studies that showed that restriction of 
phosphate in the diet was associated with no increment in the PTH levels, which may 
delay the onset of sHPT (Slatopolsky et al., 1971). The series of events that occur in 
hyperphosphatemia is represented in Figure 3. 
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The high phosphate levels induce parathyroid hormone (PTH) secretion by:  
 direct stimulation of the parathyroid glands 
 precipitation with calcium, leading to mild hypocalcemia 
 downregulating vitamin D receptors (VDR) on the parathyroid glands, causing 
vitamin D resistance. This is then seen as a loss of negative feedback on the 
parathyroid glands, causing the release of high levels of PTH (Saliba and El-
Haddad, 2009) 
sHPT at late stages progresses to involve disorders of bone as well as soft tissue 
calcifications, which may prove to be life threatening 
Poor renal clearance of phosphate  
 
 
 
 
   
 
 
 
 
 
 
 
 
Figure 3: Calcium and phosphorus metabolism in renal failure. PTH – parathyroid 
hormone, FGF-23 – fibroblasts growth factor 23. 
↓ conversion of activated 
vitamin D, downregulates 
vitamin D receptors, ↑ 
vitamin D resistance 
Hyperphosphatemia ↑ FGF-23 
Hypocalcemia 
   ↑ PTH secretion 
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1.3.2 Pathophysiology of Glandular Hyperplasia 
Cellular adaptation is a process that may be physiological or pathological. Hypertrophy 
and hyperplasia can be seen as a compensatory response to the increased demands and 
needs of the body. Organs such as the muscle undergo hypertrophy from repeated use, 
and organs such as the uterus may undergo hyperplastic changes in preparation for 
pregnancy. The parathyroid gland is not excluded from cellular adaptation, and its 
growth is stimulated by hypocalcemia and hyperphosphatemia.  
 
As CKD progresses, there is constant stimulation to produce higher amounts of PTH. In 
order to meet the high demand for production of PTH, the parathyroid glands undergo 
hyperplasia. However there are variations in the size and morphology of the gland even 
in the same patient, which differentiates parathyroid hyperplasia from other forms of 
hyperplasia in other organs (Fukagawa et al., 2006). An illustration of the progression 
of hyperplasia is pictured in Figure 4. Prolonged stimulation of the parathyroid glands 
leads to an initial diffuse polyclonal hyperplasia, followed by monoclonal nodular 
hyperplasia. At the stage of nodular hyperplasia, there is a significant decrease in 
expression of calcium-sensing receptors (CaSR) and vitamin D receptors (VDR), both 
of which are key in the regulation of parathyroid hormone production and secretion 
(Goto et al., 2008). It is postulated that nodular hyperplasia of the parathyroid glands is 
related to failed medical therapy, and hence, surgery is the treatment of choice for 
hyperparathyroidism (Tominaga et al., 2007). 
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Diffuse hyperplasia: 
Polyclonal growth 
Nodular hyperplasia: Single 
nodule with monoclonal 
growth 
Nodular hyperplasia: 
Polyclonal growth 
Diffuse hyperplasia: Early 
nodularity 
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Figure 4: Schematic representation of the stages of parathyroid gland hyperplasia 
in CKD patients based on Tominaga’s classification. 
 
1.4 Management of Secondary Hyperparathyroidism 
 
1.4.1 Medical Therapy 
 
Management of sHPT revolves around controlling hyperphosphatemia and maintaining 
calcium levels at an acceptable range. Previously, surgical indications for 
parathyroidectomy were based on the evidence of bone disease. The new trends in 
pharmaceutical drugs have strongly influenced the management of sHPT, and the 
suppression of parathyroid hormone can be achieved by phosphate binders, vitamin D 
receptor analogues, and/or calcimimetics. However, when the disease is refractory to 
medical therapy, surgery is still considered to be the treatment of choice. 
 
In our setting, most patients with CKD receive phosphate binders such as calcium 
carbonate, and vitamin D receptor analogues such as calcitriol to prevent progression of 
bone disease. However, access to newer and more effective drugs such as paricalcitol 
and cinacalcet are limited due to the high costs involved. Calcimimetics such as 
cinacalcet are superior to calcitriol in its ability to increase the sensitivity of CaSR to 
extracellular calcium and therefore reducing parathyroid gland stimulation and 
proliferation.  
 
In experiental studies, cinacalcet is seen to decrease parathyroid gland proliferation with 
reduction in size, and thus delayed the onset of secondary hyperparathyroidism 
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(Colloton et al., 2005). Meta analysis and randomized control trials involving cinacalcet 
and other conventional therapies have confirmed the superiority of cinacalcet in the 
control of hypercalcemia in CKD patients, and the reduced need for 
parathyroidectomies in patients who were administered cinacalcet. However, there was 
no proven benefit on overall mortality in those on cinacalcet (Palmer et al., 2013; Wang 
et al., 2018).  
 
Despite the evidence to support the use of cinacalcet, the role of total 
parathyroidectomy in secondary hyperparathyroidism should not be belittled. Evidence 
shows that although cinacalcet shows significant reductions in iPTH and serum calcium 
concentrations, its effects are limited to stabilization of mineral bone disease (MBD). In 
those subjected to parathyroidectomy, their biochemical parameters not only improved, 
but there was also evidence of restorative changes to the bone evidenced by 
improvements in bone densitometry (Lilit et al., 2011). 
 
The National Institute for Health and Care Excellence (NICE) have come up with the 
latest guidelines, and they do not recommend the routine use of cinacalcet in the 
treatment of secondary hyperparathyroidism in patients with end stage renal disease on 
dialysis. The use of cinacalcet was only recommended if the serum iPTH levels were 
persistently elevated and refractory to conventional therapy with vitamin D analogues, 
or if there were contraindications to parathryoidectomy. The proposed strategies for use 
of cinacalcet involved high doses of the drug, and it was deemed not cost effective for 
routine use (National Institute for Health and Care Excellence, 2007). Patients who 
were refractory to medical therapy, and had symptomatic bone disease, with persistently 
elevated levels of iPTH were referred for parathyroidectomy.  
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1.4.2 Surgical Considerations 
 
Surgical indications for parathyroidectomy are not standardized, and vary according to 
guidelines in different regions. Most guidelines stipulate a certain level of iPTH as a 
guide to when parathyroidectomy should be performed. A common cut off point is 
elevation of iPTH levels more than ten times the normal (serum iPTH > 800 pg/ml) (Pitt 
et al., 2009). However, iPTH level should not be the sole indicator to perform 
parathyroidectomy as there is no standardized iPTH assay used, and different assays 
produced a varied result.  
 
Patients who present with symptoms of bone pain, bony deformities, osteoporosis, 
pathological fractures, and soft tissue calcifications are usually in the advanced stage of 
bone disease. It would be beneficial if mineral bone disease could be detected earlier to 
prevent its progress and morbidity. Bone biopsy is the gold standard to confirm the 
presence of chronic kidney disease – mineral bone disorder (CKD – MBD) (National 
Kidney Foundation, 2017). However, this practice may not be feasible in all patients 
due to its invasive, painful nature. 
 
Pre-operative imaging in sHPT is controversial. Most centres do not practice pre-
operative imaging as it does not change the operative procedure, nor the surgical 
outcome. Patients still need to undergo bilateral neck exploration and excision of all 4 
hyperplastic glands. Imaging was only recommended in instances where there was 
recurrent sHPT, which suggested the presence of supernumerary glands, or ectopic 
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glands. Supernumerary parathyroid glands were found in up to 13% of autopsy 
specimen, and some report an incidence of up to 30% in patients with sHPT (Pattou et 
al., 2000). A combination of ultrasonography, CT scan and scintigraphy (MIBI) 
increased the sensitivity of parathyroid gland detection to 95.4%. Dual modality 
imaging of ultrasonography and CT yielded sensitivity of 95% (Lee et al., 2015).  
 
With regards to the above, the role of technetium sestamibi scan in secondary 
hyperparathyroidism is currently limited to recurrent or persistent hyperparathyroidism, 
where there is failure to identify all 4 parathyroid glands during initial surgery, or due to 
presence of supernumerary and ectopic glands.  In such cases, when scintigraphy 
confirms presence of an ectopic or supernumerary gland, a CT scan or MRI of the neck 
should be performed to delineate the anatomy and facilitate dissection during the second 
surgery (Taïeb et al., 2013). 
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1.4.3 Surgical Procedure 
 
All patients had undergone surgery under general anaesthesia. Pre-operative insertion of 
a triple lumen catheter was performed to facilitate the administration of intravenous 
calcium infusion after complete removal of the parathyroid glands, as well as for 
monitoring of calcium levels post operatively. Patients were placed in supine position 
with a sandbag in between the clavicles to better expose the neck region. A collar 
incision was made and a subplatysmal flap was raised.  
 
We proceeded to dissect up to the thyroid capsule and mobilizing the thyroid gland, 
displacing it anteriorly and medially after ligation of the middle thyroid vein. The 
posterolateral aspect of the thyroid gland is examined for any adherent parathyroid 
glands. The recurrent laryngeal nerve is not routinely identified, but in cases of difficult 
identification of the parathyroid glands, identifying the recurrent laryngeal nerve might 
aid in the discovery of the superior parathyroid glands. The superior parathyroid glands 
may sometimes be seen along the tracheo-oesophageal groove, posterior to the plane of 
the recurrent laryngeal nerve. 
 
The parathyroid glands are distinguishable from adjacent fat and lymph nodes by its 
distinctive yellow to tan appearance. In the event that the surgeon was unable to identify 
the parathyroid gland, a thymomectomy or hemithyroidectomy was performed based on 
intraoperative findings. Occasionally, cervical lymph nodes were also identified and 
removed. Upon removal of the final parathyroid gland, IV calcium was administered to 
 24 
 
prevent any episodes of life-threatening hypocalcemia. The wound was then closed in 
layers, opposing muscle and subcutaneous tissue planes with absorbable sutures. The 
skin was closed subcuticularly with absorbable sutures. 
 
There are debates on methods of parathyroidectomy, whether it should be performed 
with or without autotransplantation. The main surgical procedures performed for 
secondary hyperparathyroidism are discussed below in Table 1.1. Each procedure has 
its benefits and disadvantages. Multiple trials have been done to demonstrate the 
efficacy of total parathyroidectomy, and meta-analyses shows that it has the lowest rate 
of recurrence among the three procedures, which translates to a reduced risk of repeat 
surgery (Li et al., 2017; Liu et al., 2017). However the disadvantages of total 
parathyroidectomy is the persistent hypocalcemia that follows surgery, requiring 
lifelong calcium supplementation, not to mention the life-threatening events that may 
occur following hypocalcemia.  
 
Both subtotal parathyroidectomy and total parathyroidectomy with autotransplantation 
offer the benefits of functioning residual parathyroid tissue, thus reducing the risk of 
hypocalcemia. However in the long term, the residual functioning parathyroid tissue 
may also undergo hyperplasia, rendering the need for further surgery for removal of the 
residual glandular tissue. Subtotal parathyroidectomy has the advantage that the 
remnant of the gland keeps its native blood supply, reducing the risk of immediate post 
operative hypocalcemia. In patients who undergo autotransplantation of the gland in 
other sites, it may take time to establish a good vascular supply for the remnants of the 
gland to function. However, in the presence of recurrence, subtotal parathyroidectomy 
poses difficulties in removal of the gland from its location in the neck and the high risk 
